AJP - Lung AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (December 19, 2008). doi:10.1152/ajplung.90498.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/L470    most recent
90498.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Below, S.
Right arrow Articles by Hildebrandt, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Below, S.
Right arrow Articles by Hildebrandt, J.-P.
Submitted on September 19, 2008
Revised on December 15, 2008
Accepted on December 15, 2008

Virulence factors of Staphylococcus aureus induce Erk-MAP kinase activation and c-Fos expression in S9 and 16HBE14o- human airway epithelial cells

Sabine Below1, Anne Konkel1, Cathrin Zeeck1, Christian Müller1, Christian Kohler1, Susanne Engelmann1, and Jan-Peter Hildebrandt1*

1 University of Greifswald

* To whom correspondence should be addressed. E-mail: jph{at}uni-greifswald.de.

Part of the innate defence of bronchial epithelia against bacterial colonization is regulated secretion of salt, water and mucus as well as defensins and cytokines involving MAP kinase activation and alterations in early gene expression. We tested two different types of immortalized human airway epithelial cells (S9, 16HBE14o-) for activation of Erk-type MAP kinases and for expression of c-Fos upon treatment with Staphylococcus aureus-culture supernatants from the stationary growth phase (OD540nm = 10) or with recombinant S. aureus-hemolysins (Hla, Hlb). OD10-supernatants activated Erk-type MAP kinases and c-Fos expression in a concentration-dependent manner. Hla induced Erk-type kinase phosphorylation in S9-, but not in 16HBE14o- cells. Hlb induced Erk-activation in either cell type. Basal and stimulated levels of Erk-type MAP kinase phosphorylation were sensitive to the Mek1-inhibitor PD98059 indicating that the bacterial products activated the entire signalling cascade which co-regulates IL-8 induction and secretion. While c-Fos expression was enhanced by OD10-supernatants, Hla and Hlb in S9 cells, 16HBE14o- cells responded to OD10-supernatant and Hlb, but not to Hla. In S9 cells, PD98059 suppressed c-Fos upregulation by OD10-supernatant, Hla or Hlb indicating that c-Fos expression requires activation of Erk-type MAP kinases. In 16HBE14o- cells, however, c-Fos expression by OD10-supernatant was sensitive to PD98059, while that induced by Hlb was not. This indicates that ingredients of OD10-supernatants other than Hla or Hlb are activating Erk-type MAP kinases in 16HBE14o- cells and that other intracellular signalling systems apart from Erk-type MAP kinases contribute to Hlb-mediated regulation of c-Fos. Thus, interaction of bacterial factors with airway epithelial cells may be highly cell type-specific.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.